Compare Stocks

Calamos Dynamic Convertible and Income Fund is a closed ended fixed income mutual fund launched by Calamos Investments LLC. It is managed by Calamos Advisors LLC. The fund invests in the fixed income markets of the United States. It primarily invests in a portfolio of convertible securities, investment grade and below investment grade bonds, loans, equity-linked notes, and floating rate securities. The fund also invests through derivatives such as options. It employs fundamental analysis with a top-down global macroeconomic approach to create its portfolio. Calamos Dynamic Convertible and Income Fund was formed on March 11, 2014 and is domiciled in the United States.

Global Energy Metals Corporation engages in the exploration for resource properties in Canada, Australia, and the United States. It explores for cobalt, copper, nickel, gold, silver, and base metal deposits. The company holds interests in the Werner Lake property located in Kenora, Ontario; the Millennium and Mount Isa projects situated in Mount Isa, Queensland; and the Lovelock Mine and Treasure Box projects in Churchill County, Nevada. It also holds interest in the Rana nickel-copper-cobalt project, which include the Bruvann nickel mine located in Northern Norway. In addition, the company holds interest in the Monument Peak copper-silver-gold property covering an area of approximately 558.5 hectares located in the Idaho; and the Chance Lake property comprising various contiguous claims, which covers approximately 777.7 hectares; and the Amiral property comprising various contiguous mineral claims covering an area of approximately 2,162.5 hectares located in Quebec, Canada. The company was incorporated in 2015 and is headquartered in Vancouver, Canada.

GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on treating inflammatory, fibrotic, and autoimmune diseases in the United States. Its product pipeline comprises GRI-0621, which is in phase II clinical development for the treatment of idiopathic pulmonary fibrosis; GRI-0803 which is in phase I trial for the treatment of systematic lupus erythematosus; GRI-0124, which is in pre-clinical development for the treatment of primary sclerosing cholangitis; and GRI-0729 in pre-clinical development. The company also develops ADAIR and ADMIR for treatment of attention -deficit/hyperactivity disorder. GRI Bio, Inc. was formerly known as Glycoregimmune, Inc. GRI Bio, Inc. was founded in 2009 and is based in LA Jolla, California.

Goldstrike Resources Ltd. acquires, explores for, and develops mineral properties in Canada. The company explores for gold deposits. Its principal property is the Plateau North and Plateau South areas, which includes approximately 3,167 contiguous quartz claims covering an area of 662 square kilometers in Yukon Territory, Canada. The company was formerly known as AccelRate Power Systems Inc. and changed its name to Goldstrike Resources Ltd. in June 2011. Goldstrike Resources Ltd. is headquartered in Vancouver, Canada.